These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6256002)

  • 1. Adenylate cyclase in silkworm. Effects of adenosine 3'-phosphate and 2'-deoxyadenosine 3'-phosphate on the enzyme system in fat body.
    Morishima I
    Biochim Biophys Acta; 1980 Jun; 613(2):507-13. PubMed ID: 6256002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of guanylate cyclase by guanosine 3'-phosphate and 2'-deoxyguanosine 3'-phosphate in silkworm fat body.
    Morishima I
    J Biochem; 1982 Mar; 91(3):905-9. PubMed ID: 6122683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenylate cyclase in silkworm. Properties of the enzyme in pupal fat body.
    Morishima I
    J Biochem; 1978 Dec; 84(6):1495-500. PubMed ID: 104981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis.
    Londos C; Cooper DM; Schlegel W; Rodbell M
    Proc Natl Acad Sci U S A; 1978 Nov; 75(11):5362-6. PubMed ID: 214785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pitfalls in the use of lead nitrate for the histochemical demonstration of adenylate cyclase activity.
    Lemay A; Jarett L
    J Cell Biol; 1975 Apr; 65(1):39-50. PubMed ID: 165205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine sperm adenylate cyclase. Inhibition by adenosine and adenosine analogs.
    Brown MA; Casillas ER
    J Androl; 1984; 5(5):361-8. PubMed ID: 6094410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cylic nucleotide phosphodiesterase in silkworm. Characterization of cyclic GMP phosphodiesterase.
    Morishima I
    Biochim Biophys Acta; 1975 Dec; 410(2):310-7. PubMed ID: 1092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cation and structural requirements for P site-mediated inhibition of adenylate cyclase.
    Johnson RA; Yeung SM; Stübner D; Bushfield M; Shoshani I
    Mol Pharmacol; 1989 May; 35(5):681-8. PubMed ID: 2498637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine and adenine nucleotides stimulation of skin (epidermal) adenylate cyclase.
    Iizuka H; Adachi K; Halprin KM; Levine V
    Biochim Biophys Acta; 1976 Oct; 444(3):685-93. PubMed ID: 186102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fat cell membrane adenylate cyclase by 2'-deoxyadenosine-3'-monophosphate,
    Sahyoun N; Schmitges CJ; Siegel MI; Cuatrecasas P
    Life Sci; 1976 Dec; 19(12):1971-9. PubMed ID: 826749
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of the divalent cations Mg2+ and Mn2+ on adenylate cyclase activity in white and brown adipose tissue of lean and obese (ob/ob) mice.
    Bégin-Heick N
    Can J Biochem Cell Biol; 1985 Jan; 63(1):7-15. PubMed ID: 3986664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NaF and guanine nucleotides modulate adenylate cyclase activity in NG108-15 cells by interacting with both Gs and Gi.
    Kelly E; Keen M; Nobbs P; MacDermot J
    Br J Pharmacol; 1990 Jun; 100(2):223-30. PubMed ID: 1696150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of feedback regulator on adenylate cyclase.
    Ho RJ; Sutherland EW
    Proc Natl Acad Sci U S A; 1975 May; 72(5):1773-7. PubMed ID: 168575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated adenosine derivatives as low-affinity adenosine-receptor agonists. Methodological implications for the adenylate cyclase assay.
    Schütz W; Steurer G; Tuisl E; Plass H
    Biochem J; 1984 May; 220(1):207-12. PubMed ID: 6331407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine-mediated stimulation of bone cell adenylate cyclase activity.
    Peck WA; Carpenter JG; Schuster RJ
    Endocrinology; 1976 Sep; 99(3):901-9. PubMed ID: 182472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction between the adenylate cyclase system and insulin-stimulated glucose transport. Evidence for the importance of both cyclic-AMP-dependent and -independent mechanisms.
    Lönnroth P; Davies JI; Lönnroth I; Smith U
    Biochem J; 1987 May; 243(3):789-95. PubMed ID: 2821992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clofibrate on the human fat cell adenylate cyclase system.
    Kather H; Simon-Crisan G; Vogt B; Simon B
    Horm Metab Res; 1977 Jul; 9(4):300-4. PubMed ID: 196990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Dictyostelium discoideum adenylate cyclase by manganese and adenosine analogs.
    Khachatrian L; Klein C; Howlett A
    Biochim Biophys Acta; 1987 Feb; 927(2):235-46. PubMed ID: 2880607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.